Sole Source Notice NovaSeq 6000.pdf

The Uniformed Services University of the Health Sciences (USU) is the Nation's federal health sciences university and is committed to excellence in military medicine and public health during peace and war.

We provide the Nation with health professionals dedicated to career service in the Department of Defense and the United States Public Health Service and with scientists who serve the common good.

We serve the uniformed services and the Nation as an outstanding academic health sciences center with a worldwide perspective for education, research, service, and consultation; we are unique in relating these activities to military medicine, disaster medicine, and military medical readiness. USU is located in Bethesda, MD on the grounds of the Naval Support Activity Bethesda.

The mission of USU is to provide the highest quality education programs in the health sciences to those selected individuals who demonstrate dedication to a health profession career in the Uniformed Services. As such, it is essential USU provide the necessary training and equipment required for our students to become successful doctors and nurses and to be able to provide the best care possible for our soldiers and to support our research efforts.

USU intends to negotiate on a sole source basis with Illumina, Inc., located in San Diego, CA for two (2) NovaSeq 6000 Sequencing Systems to include installation, training, and 12 months warranty (including parts and labor).

This supply will be procured in accordance with the procedures of FAR Part 12-Commercial Items and FAR Part 13-Simplified Acquisition Procedures.

Sole source determination is made in accordance with: FAR Part 13.501(a) Sole source (including brand name) acquisitions, which states that acquisitions solicited from only one source be justified in writing with the justification approved at the levels specified in FAR 13.501(a)(2) and made publicly available.

Illumina, Inc. is the global leader in innovative genome sequencing technologies and is the only supplier of next generation sequencing platforms for human whole genome sequencing at population scale.

Illumina, Inc. holds several patents for the proprietary technology used with the NovaSeq 6000 Sequencing System. The global Genome Core facilities all utilize Illumina platforms and Illumina, Inc. has numerous collaborative interactions and solutions for population genomics research and clinical diagnostics. Illumina, Inc. also provides Field Service Engineering and Field Application Specialists that currently support operations at USU for The Collaborative Health Initiative Research Program (CHIRP) Laboratory Core.

Illumina, Inc. is the only known entity that can provide the specific needs of USU’s requirement.

This is not a request for quotes and a solicitation package will not be issued. In accordance with 5.207(c)(16)(i), all responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency. Responses to this notice must demonstrate clear and convincing evidence that competition would be advantageous to the Government, would not be cost or time prohibitive, and that the interested offerors are authorized to supply and service the system. Information received will be considered for the purposes of determining whether to conduct a competitive procurement. The Government will not be responsible for any costs incurred by responding to this notice.

Responses must be received via email at (emily.mashek@usuhs.edu) by 12:00 PM EST on 23 July 2020.